438 related articles for article (PubMed ID: 29019492)
41. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
42. Novel prodrugs with a spontaneous cleavable guanidine moiety.
Hamada Y
Bioorg Med Chem Lett; 2016 Apr; 26(7):1685-9. PubMed ID: 26923694
[TBL] [Abstract][Full Text] [Related]
43. A DNA origami nanostructure embedded with NQO1-activated prodrugs for precision drug delivery.
He Z; Xiang W; Fan Q; Wang L; Chao J
Chem Commun (Camb); 2023 Jan; 59(7):912-915. PubMed ID: 36594872
[TBL] [Abstract][Full Text] [Related]
44. Prodrug-Based Cascade Self-Assembly Strategy for Precisely Controlled Combination Drug Therapy.
Ha W; Zhao XB; Chen XY; Jiang K; Shi YP
ACS Appl Mater Interfaces; 2018 Jun; 10(25):21149-21159. PubMed ID: 29874031
[TBL] [Abstract][Full Text] [Related]
45. Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension.
Mertz N; Larsen SW; Kristensen J; Østergaard J; Larsen C
J Pharm Sci; 2016 Oct; 105(10):3079-3087. PubMed ID: 27475785
[TBL] [Abstract][Full Text] [Related]
46. Do prodrugs deliver?
Smith DA
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
[TBL] [Abstract][Full Text] [Related]
47. Stimulus-responsive self-assembled prodrugs in cancer therapy.
Dong X; Brahma RK; Fang C; Yao SQ
Chem Sci; 2022 Apr; 13(15):4239-4269. PubMed ID: 35509461
[TBL] [Abstract][Full Text] [Related]
48. Prodrug approaches for CNS delivery.
Rautio J; Laine K; Gynther M; Savolainen J
AAPS J; 2008; 10(1):92-102. PubMed ID: 18446509
[TBL] [Abstract][Full Text] [Related]
49. Amino acids as promoieties in prodrug design and development.
Vig BS; Huttunen KM; Laine K; Rautio J
Adv Drug Deliv Rev; 2013 Oct; 65(10):1370-85. PubMed ID: 23099277
[TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor Atazanavir.
A M Subbaiah M; Mandlekar S; Desikan S; Ramar T; Subramani L; Annadurai M; Desai SD; Sinha S; Jenkins SM; Krystal MR; Subramanian M; Sridhar S; Padmanabhan S; Bhutani P; Arla R; Singh S; Sinha J; Thakur M; Kadow JF; Meanwell NA
J Med Chem; 2019 Apr; 62(7):3553-3574. PubMed ID: 30938524
[TBL] [Abstract][Full Text] [Related]
51. To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability.
Damião MC; Pasqualoto KF; Polli MC; Parise Filho R
J Pharm Pharm Sci; 2014; 17(4):532-40. PubMed ID: 25579432
[TBL] [Abstract][Full Text] [Related]
52. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
[TBL] [Abstract][Full Text] [Related]
53. New Generation Nanomedicines Constructed from Self-Assembling Small-Molecule Prodrugs Alleviate Cancer Drug Toxicity.
Wang H; Lu Z; Wang L; Guo T; Wu J; Wan J; Zhou L; Li H; Li Z; Jiang D; Song P; Xie H; Zhou L; Xu X; Zheng S
Cancer Res; 2017 Dec; 77(24):6963-6974. PubMed ID: 29055017
[TBL] [Abstract][Full Text] [Related]
54. Click and Release: A Chemical Strategy toward Developing Gasotransmitter Prodrugs by Using an Intramolecular Diels-Alder Reaction.
Ji X; Zhou C; Ji K; Aghoghovbia RE; Pan Z; Chittavong V; Ke B; Wang B
Angew Chem Int Ed Engl; 2016 Dec; 55(51):15846-15851. PubMed ID: 27879021
[TBL] [Abstract][Full Text] [Related]
55. smProdrugs: A repository of small molecule prodrugs.
Choudhury C; Kumar V; Kumar R
Eur J Med Chem; 2023 Mar; 249():115153. PubMed ID: 36724634
[TBL] [Abstract][Full Text] [Related]
56. Self-assembled drug delivery systems: Part 3. In vitro/in vivo studies of the self-assembled nanoparticulates of cholesteryl acyl didanosine.
Jin Y; Ai P; Xin R; Tian Y; Dong J; Chen D; Wang W
Int J Pharm; 2009 Feb; 368(1-2):207-14. PubMed ID: 19007871
[TBL] [Abstract][Full Text] [Related]
57. Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.
Mathuber M; Schueffl H; Dömötör O; Karnthaler C; Enyedy ÉA; Heffeter P; Keppler BK; Kowol CR
Inorg Chem; 2020 Dec; 59(23):17794-17810. PubMed ID: 33222438
[TBL] [Abstract][Full Text] [Related]
58. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
59. Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.
Wu L; Zhang F; Chen X; Wan J; Wang Y; Li T; Wang H
ACS Appl Mater Interfaces; 2020 Jan; 12(3):3327-3340. PubMed ID: 31872760
[TBL] [Abstract][Full Text] [Related]
60. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Vooturi SK; Kadam RS; Kompella UB
Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
